论文部分内容阅读
背景虽然有许多靶向治疗药物应用于临床,如5-氟尿嘧啶(5-FU)为基本的化疗方案应用40年来,降低了癌症的复发率和死亡率,但是结直肠癌(CRC)仍然是西方国家癌症致死的首位原因。治疗的主要障碍
Background Although there are many targeted therapies for clinical use such as 5-fluorouracil (5-FU) -based chemotherapeutic regimens for 40 years, reducing the recurrence and mortality of cancers, CRC remains the western The leading cause of cancer death in the country. The main obstacle to treatment